Ariane L. Herrick

25.9k total citations · 1 hit paper
319 papers, 8.7k citations indexed

About

Ariane L. Herrick is a scholar working on Pathology and Forensic Medicine, Dermatology and Surgery. According to data from OpenAlex, Ariane L. Herrick has authored 319 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 264 papers in Pathology and Forensic Medicine, 150 papers in Dermatology and 54 papers in Surgery. Recurrent topics in Ariane L. Herrick's work include Systemic Sclerosis and Related Diseases (264 papers), Dermatologic Treatments and Research (136 papers) and Mast cells and histamine (42 papers). Ariane L. Herrick is often cited by papers focused on Systemic Sclerosis and Related Diseases (264 papers), Dermatologic Treatments and Research (136 papers) and Mast cells and histamine (42 papers). Ariane L. Herrick collaborates with scholars based in United Kingdom, United States and Italy. Ariane L. Herrick's co-authors include Tonia Moore, Michael Hughes, Andrea Murray, Christopher P. Denton, M I Jayson, Joanne Manning, S. Hollis, Marina Anderson, Anthony J. Freemont and Alan J. Silman and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Ariane L. Herrick

299 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A multicenter, prospective, randomized, double‐blind, placebo‐controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

2006 484 citations Ariane L. Herrick, Neil McHugh et al. Arthritis & Rheumatism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ariane L. Herrick United Kingdom	51	6.3k	3.4k	1.8k	1.4k	1.4k	319	8.7k
Jérôme Avouac France	55	4.9k 0.8×	1.6k 0.5×	1.9k 1.0×	2.2k 1.6×	703 0.5×	253	8.3k
Fredrick M. Wigley United States	62	7.0k 1.1×	2.5k 0.8×	1.9k 1.1×	4.0k 2.8×	1.8k 1.3×	222	12.3k
Serena Guiducci Italy	48	4.1k 0.7×	1.6k 0.5×	1.5k 0.8×	1.4k 1.0×	708 0.5×	227	6.4k
Alan Tyndall Switzerland	49	3.2k 0.5×	915 0.3×	1.6k 0.9×	1.4k 1.0×	1.1k 0.8×	158	7.2k
Richard M. Silver United States	49	4.1k 0.6×	1.0k 0.3×	1.1k 0.6×	2.9k 2.1×	712 0.5×	167	7.1k
E. Carwile LeRoy United States	51	9.5k 1.5×	3.9k 1.2×	2.4k 1.3×	2.3k 1.6×	1.2k 0.9×	149	13.1k
Gabriela Riemekasten Germany	48	3.3k 0.5×	1.1k 0.3×	2.9k 1.6×	1.7k 1.2×	487 0.4×	237	7.1k
Yannick Allanore France	69	11.1k 1.8×	3.6k 1.1×	3.9k 2.2×	5.5k 3.9×	1.5k 1.0×	480	16.7k
Robert W. Simms United States	39	2.3k 0.4×	826 0.2×	928 0.5×	1.0k 0.7×	363 0.3×	87	5.5k
Chester V. Oddis United States	45	1.2k 0.2×	1.0k 0.3×	1.4k 0.8×	1.5k 1.1×	680 0.5×	150	7.6k

Countries citing papers authored by Ariane L. Herrick

Since Specialization

Citations

This map shows the geographic impact of Ariane L. Herrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariane L. Herrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariane L. Herrick more than expected).

Fields of papers citing papers by Ariane L. Herrick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariane L. Herrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariane L. Herrick. The network helps show where Ariane L. Herrick may publish in the future.

Co-authorship network of co-authors of Ariane L. Herrick

This figure shows the co-authorship network connecting the top 25 collaborators of Ariane L. Herrick. A scholar is included among the top collaborators of Ariane L. Herrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariane L. Herrick. Ariane L. Herrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wilkinson, Sarah, Jack Wilkinson, Debra Lyon, et al.. (2025). Imaging the microvasculature using nailfold capillaroscopy in patients with coronavirus disease-2019; A cross-sectional study. Microvascular Research. 159. 104796–104796.

Villar, María José, Stefano Di Donato, Joanne Manning, et al.. (2025). Thermographic abnormalities associate with electrocardiogram/echocardiographic changes and mortality in systemic sclerosis: a retrospective cohort study. Lara D. Veeken. 64(11). 5883–5891.

Reynolds, John A., Ariane L. Herrick, Sahena Haque, et al.. (2024). Clinical trial eligibility of a real-world connective tissue disease cohort: Results from the LEAP cohort. Seminars in Arthritis and Rheumatism. 67. 152463–152463. 1 indexed citations

Herrick, Ariane L., et al.. (2024). Descriptor: Voice Pre-Processing and Quality Assessment Dataset (VPQAD). 1. 146–153. 1 indexed citations

Ross, Rebecca L., Emily L. Clarke, Christopher W. Wasson, et al.. (2024). Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with Very Early Diagnosis of Systemic Sclerosis (VEDOSS). Lara D. Veeken. 64(6). 3606–3617. 4 indexed citations

Ross, Laura, Dylan Hansen, Susanna Proudman, et al.. (2024). Development and Initial Validation of the Novel Scleroderma Clinical Trials Consortium Activity Index. Arthritis & Rheumatology. 76(11). 1635–1644. 1 indexed citations

Lorenzis, Enrico De, Stefano Di Donato, Michelle Wilson, et al.. (2024). Clinical trajectories of hand function impairment in systemic sclerosis: an unmet clinical need across disease subsets. RMD Open. 10(1). e003216–e003216. 6 indexed citations

Pauling, John D, Lan Yu, Tracy Frech, et al.. (2023). Construct validity and reliability of the Assessment of Systemic Sclerosis-Associated Raynaud’s Phenomenon (ASRAP) questionnaire. Lara D. Veeken. 63(5). 1281–1290. 8 indexed citations

Volkmann, Elizabeth R., Zsuzsanna H. McMahan, Vanessa Smith, et al.. (2023). Risk of Malnutrition in Patients With Systemic Sclerosis‐Associated Interstitial Lung Disease Treated With Nintedanib in the Randomized, Placebo‐Controlled SENSCIS Trial. Arthritis Care & Research. 75(12). 2501–2507. 4 indexed citations

10.

Herrick, Ariane L., et al.. (2022). POS0478 TOPICAL CALCIUM CHELATORS FOR TARGETING CUTANEOUS CALCIFICATION: PRECLINICAL EVIDENCE OF EFFICACY. Annals of the Rheumatic Diseases. 81. 493–494. 1 indexed citations

11.

Vanhaecke, Amber, Maurizio Cutolo, Oliver Distler, et al.. (2022). Nailfold capillaroscopy in SSc: innocent bystander or promising biomarker for novel severe organ involvement/progression?. Lara D. Veeken. 61(11). 4384–4396. 22 indexed citations

12.

Reynolds, John A., Ariane L. Herrick, Sahena Haque, et al.. (2022). Determinants of health-related quality of life across the spectrum of connective tissue diseases using latent profile analysis: results from the LEAP cohort. Lara D. Veeken. 62(8). 2673–2682. 4 indexed citations

13.

Dinsdale, Graham, Sarah Wilkinson, Jack Wilkinson, et al.. (2020). State-of-the-art technologies provide new insights linking skin and blood vessel abnormalities in SSc-related disorders. Microvascular Research. 130. 104006–104006. 11 indexed citations

14.

Pauling, John D, Tracy Frech, Michael Hughes, et al.. (2016). Attitudes Toward Patient-Reported Outcome Instruments for the Assessment of Raynaud’s Phenomenon in Systemic Sclerosis. Arthritis & Rheumatism. 68(10). 1 indexed citations

15.

Belch, J. J. F., David Fiorentino, Ariane L. Herrick, et al.. (2008). MQX-503, a novel topical nitroglycerin formulation, improves severity of symptoms associated with Raynaud's phenomenon. Discovery Research Portal (University of Dundee). 58(9). 622–622. 4 indexed citations

16.

Rueda‐Medina, Blanca, Carmen Pilar Simeón‐Aznar, Roger Hesselstrand, et al.. (2008). A large multicenter analysis of CTGF-945 promoter polymorphism does not confirm association with systemic Sclerosis susceptibility or phenotype. Lund University Publications (Lund University). 58(9). 588–589. 1 indexed citations

17.

Murray, Andrea, Rachel Gorodkin, Tonia Moore, et al.. (2004). Comparison of red and green laser doppler imaging of blood flow. Lasers in Surgery and Medicine. 35(3). 191–200. 30 indexed citations

18.

Black, Carol M., Alan J. Silman, Ariane L. Herrick, et al.. (1999). Interferon-? does not improve outcome at one year in patients with diffuse cutaneous scleroderma: Results of a randomized, double-blind, placebo-controlled trial. Arthritis & Rheumatism. 42(2). 299–305. 146 indexed citations

19.

Pringle, Steven, Patrick Waller, Ariane L. Herrick, et al.. (1993). Effects of atenolol withdrawal in patients on triple antihypertensive therapy.. PubMed. 7(1). 89–93. 3 indexed citations

20.

Herrick, Ariane L., et al.. (1991). Cholelithiasis in patients with variegate porphyria. Journal of Hepatology. 12(1). 50–53. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact